OHLCX Market Research
Delayed

MRNA

Moderna is a biotechnology company that focuses on drug discovery and development based on messenger RNA (mRNA) technology.

−0.03 (−0.02%) Nov 20, 2026 19:57 ET Delayed
Open
198.18
High
210.00
Low
191.46
Prev close
199.33
Volume
10M
Avg vol 10
9M

Today · Market closed · opens Mon 9:30 AM

Price

MRNA chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 199.30

Strong sellNeutralStrong buy
Sell
score −0.11 · 18 signalling
5Buy
6Neutral
7Sell

Leaning sell. 7 of 18 signals point down against 5 up, carried by trend. Momentum is mostly neutral. Volatility is mostly neutral. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is strong (ADX 27).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −0.81 · Signal 6.31 · Hist −7.12
Sell
ADX 14
Strong trend, −DI slightly ahead
ADX 27.24 · +DI 19.97 · −DI 24.30
Sell
Parabolic SAR 0.02, 0.2
Above price, 65.79 over the close
265.09
Sell
Ichimoku 9, 26, 52
Price inside the cloud, conversion above base
Conv 231.49 · Base 230.17 · A 199.36 · B 148.00
Neutral

Momentum

RSI 14
Mid-range, no extreme
42.49
Neutral
Stoch 14, 3
Oversold, %K still above %D
%K 10.26 · %D 6.96
Buy
Stoch RSI 14, 14, 3, 3
Oversold, %K still above %D
%K 2.61 · %D 1.31
Buy
Williams %R 14
Oversold zone, falling
−89.74
Neutral
CCI 14
Below −100, turning up
−103.89
Buy
MFI 14
Below midpoint, not oversold
46.54
Neutral
ROC 12
Price down 22.87% over 12 bars
−22.87%
Sell
AO 5, 35
Below zero and falling
−14.35
Sell
TRIX 18
Above zero
0.652
Buy
KST 10/15/20/30, 3
Below its signal line
KST 83.94 · Signal 111.27
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.19
Up 268.18 · Mid 225.47 · Low 182.77
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 246.70 · Mid 219.65 · Low 192.61
Neutral

Volume

VWAP 345-bar
Close 123.1% above VWAP
89.33
Buy
Force Index 1
Negative, sellers in control
−290.9K
Sell
ATR
18.42
9.24% of close
A/D Line
341.6M
cumulative
OBV
422.6M
cumulative
Volume Profile
22.28 – 40.75
POC · bull 800.2M · bear 657.7M · 55 / 45
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-3.77%

Change in value over the past month.

3 month return

40.40%

Change in value over the last three months.

Max drawdown

34.16%

Largest fall from a peak to the low that followed.

Standard deviation

204.91%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.59

Return above the risk-free rate per unit of volatility.

Calmar ratio

9.56

Annualised return against the maximum drawdown.

About

MRNA summary

Loading summary…

Questions

MRNA, answered

How does Moderna ensure the safety of its products?

Moderna conducts extensive preclinical and clinical trials to evaluate the safety and efficacy of its products before they reach the market.

How can investors purchase MRNA stock?

Investors can purchase MRNA stock through a brokerage account, similar to any publicly traded stock.

What is the outlook for Moderna’s future growth?

Moderna is well-positioned for growth, given its pioneering role in mRNA technology and ongoing development of new therapies.

Is Moderna publicly traded?

Yes, Moderna is publicly traded on the NASDAQ under the ticker symbol MRNA.

What are the risks of investing in Moderna?

Investing in Moderna involves risks such as regulatory hurdles, competition, and market demand for its products.

How does Moderna address public health needs?

Moderna focuses on developing vaccines and treatments for public health challenges, responding to emerging infectious diseases.

What other therapeutic areas is Moderna exploring?

Moderna is exploring therapies for infectious diseases, cancer, and rare diseases, leveraging its mRNA platform.

What partnerships does Moderna have?

Moderna has established partnerships with various organizations, including government agencies and pharmaceutical companies, to enhance its research and development capabilities.

What is mRNA technology?

mRNA technology uses synthetic messenger RNA to instruct cells to produce proteins that can help prevent or fight diseases.

What is the status of Moderna’s vaccine pipeline?

Moderna has a robust pipeline of mRNA vaccines and therapeutics currently in various stages of clinical trials.

News

MRNA in the news

Enhance Your MRNA Trading Now

Empower your trading with OHLCX.com. Our comprehensive platform delivers precise analysis and strategic insights for MRNA, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.